Diaceutics, the diagnostic commercialization company that improves patient outcomes via better diagnostic testing, today announces that it has raised $5 million in new mezzanine financing from two partners, WhiteRock Capital Partners* and Silicon Valley Bank. The money will be used to support the organization’s continued global expansion.
